Viridian Therapeutics, Inc. (VRDN) has 20 bekannte Insider- und institutionelle Anteilseigner verzeichnet. Der größte Anteilseigner ist Logos Global Master Fund LP mit 6,000,000 Aktien. Weitere bedeutende Anteilseigner sind Fairmount Funds Management LLC und Atlas Venture Fund VII L P.
In den letzten 12 Monaten haben Insider 25 Transaktionen in VRDN Aktien getätigt — 12 Käufe (im Wert von $11.82M) und 1 Verkäufe (im Wert von $70.8K). Insider-Käufe haben die Verkäufe übertroffen, was auf Vertrauen in die Unternehmensaussichten hindeuten kann.
VRDN Insider-Beteiligungen
Größter Aktionär
Logos Global Master Fund LP
6,000,000 Aktien
Käufe (12 Monate)
12
$11.82M Wert
Verkäufe (12 Monate)
1
$70.8K Wert
12-Monats-Transaktionsaktivität
Top-Insider-Aktionäre
| # |
Name |
Funktion |
Gehaltene Aktien |
Zuletzt gemeldet |
Relative Größe |
| 1 |
Logos Global Master Fund Lp |
10 Percent Owner |
6,000,000 |
2020-11-16 |
|
| 2 |
Fairmount Funds Management Llc |
10 Percent Owner |
3,914,458 |
2025-10-27 |
|
| 3 |
Atlas Venture Fund Vii L P |
10 Percent Owner |
3,142,580 |
2017-02-13 |
|
| 4 |
Remeditex Ventures Llc |
10 Percent Owner |
2,706,563 |
2017-02-13 |
|
| 5 |
Frazier Life Sciences Public Fund, L.p. |
10 Percent Owner |
1,505,200 |
2021-09-28 |
|
| 6 |
Fairmount Healthcare Fund Ii L.p. |
Director |
1,363,764 |
2022-08-19 |
|
| 7 |
Marshall William Stuart |
President & CEO |
464,000 |
2020-02-14 |
|
| 8 |
Point72 Asset Management, L.p. |
10 Percent Owner |
426,162 |
2020-11-20 |
|
| 9 |
Ra Capital Management, L.p. |
10 Percent Owner |
410,686 |
2020-12-17 |
|
| 10 |
Leverone Jason A. |
Chief Financial Officer |
311,785 |
2021-01-20 |
|
| 11 |
Escolar Diana |
Chief Medical Officer |
270,000 |
2020-02-14 |
|
| 12 |
Myers Scott Dunseth |
Chief Executive Officer |
259,500 |
2023-04-12 |
|
| 13 |
Violin Jonathan |
Chief Executive Officer |
239,205 |
2023-02-07 |
|
| 14 |
Riccitelli Samuel D |
President & CEO |
200,000 |
2016-05-19 |
|
| 15 |
Humer Kristian |
CFO and Cbo |
108,000 |
2023-02-10 |
|
| 16 |
Katz Barrett |
Chief Medical Officer |
108,000 |
2023-02-10 |
|
| 17 |
Rubin Paul D |
EVP, Research & Development |
87,000 |
2019-02-08 |
|
| 18 |
Levy Adam Scott |
Chief Business Officer |
74,000 |
2019-02-08 |
|
| 19 |
Melvin Carrie |
COO |
54,000 |
2023-02-10 |
|
| 20 |
Ciulla Thomas |
Chief Medical Officer |
50,000 |
2024-02-07 |
|
Aktuelle Transaktionen (letzte 12 Monate)
| Datum |
Name |
Funktion |
Typ |
Aktien |
Kurs |
Wert |
| 2026-03-03 |
Tousignant Jennifer |
Chief Legal Officer |
RSU-Steuereinbehalt |
1,675 |
$30.19 |
$50.57K |
| 2026-03-03 |
Harmon Seth |
Chief Financial Officer |
RSU-Steuereinbehalt |
2,031 |
$30.19 |
$61.32K |
| 2026-03-03 |
Mahoney Stephen F. |
President and CEO |
RSU-Steuereinbehalt |
7,408 |
$30.19 |
$223.65K |
| 2026-03-03 |
Beetham Thomas W. |
Chief Operating Officer |
RSU-Steuereinbehalt |
3,048 |
$30.19 |
$92.02K |
| 2026-03-03 |
Tousignant Jennifer |
Chief Legal Officer |
RSU-Steuereinbehalt |
1,724 |
$29.32 |
$50.55K |
| 2026-03-02 |
Tousignant Jennifer |
Chief Legal Officer |
RSU-Zuteilung |
23,850 |
- |
- |
| 2025-03-03 |
Tousignant Jennifer |
Officer |
Unbekannt |
- |
- |
- |
| 2026-03-03 |
Harmon Seth |
Chief Financial Officer |
RSU-Steuereinbehalt |
2,091 |
$29.32 |
$61.31K |
| 2026-03-02 |
Harmon Seth |
Chief Financial Officer |
RSU-Zuteilung |
20,550 |
- |
- |
| 2025-03-03 |
Harmon Seth |
Officer |
Unbekannt |
- |
- |
- |
| 2026-03-02 |
Tripuraneni Radhika |
Chief Medical Officer |
RSU-Zuteilung |
19,150 |
- |
- |
| 2026-03-03 |
Mahoney Stephen F. |
President and CEO |
RSU-Steuereinbehalt |
7,627 |
$29.32 |
$223.62K |
| 2026-03-02 |
Mahoney Stephen F. |
President and CEO |
RSU-Zuteilung |
111,900 |
- |
- |
| 2026-03-03 |
Beetham Thomas W. |
Chief Operating Officer |
RSU-Steuereinbehalt |
3,138 |
$29.32 |
$92.01K |
| 2026-03-02 |
Beetham Thomas W. |
Chief Operating Officer |
RSU-Zuteilung |
35,300 |
- |
- |
| 2025-12-31 |
Tousignant Jennifer |
Chief Legal Officer |
Informierter Verkauf |
2,272 |
$31.16 |
$70.8K |
| 2025-10-23 |
Fairmount Funds Management Llc |
10 Percent Owner |
Informierter Kauf |
454,545 |
$22.00 |
$10M |
| 2025-07-01 |
Gheuens Sarah |
Director |
RSU-Zuteilung |
21,000 |
$14.47 |
$303.87K |
| 2025-07-01 |
Kiselak Tomas |
Director |
RSU-Zuteilung |
21,000 |
$14.47 |
$303.87K |
| 2025-07-01 |
Cain Christopher W. |
Director |
RSU-Zuteilung |
21,000 |
$14.47 |
$303.87K |
| 2025-07-01 |
Moses Jennifer K. |
Director |
RSU-Zuteilung |
21,000 |
$14.47 |
$303.87K |
| 2025-07-01 |
Ajer Jeffrey Robert |
Director |
RSU-Zuteilung |
21,000 |
$14.47 |
$303.87K |
| 2025-07-01 |
Morris Arlene |
Director |
RSU-Zuteilung |
21,000 |
$14.47 |
$303.87K |
| 2025-06-10 |
Fairmount Funds Management Llc |
10 Percent Owner |
Optionsausübung (Verkauf) |
12,500 |
$12.31 |
$153.88K |
| 2025-06-09 |
Fairmount Funds Management Llc |
10 Percent Owner |
Optionsausübung (Verkauf) |
1,600 |
$7.80 |
$12.48K |
